Targeted integration of a rAAV vector into the AAVS1 region

Virology

Volumn 433, Issue 2, 2012, Pages 356-366

  Ward, Peter ^a   Walsh, Christopher E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

AAVS1; Adeno associated virus (AAV); Ex vivo gene therapy; Site specific integration

Indexed keywords

PARVOVIRUS VECTOR; VIRUS DNA;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL CLONING; CELL CULTURE; CELL STRAIN HEPG2; CHROMOSOME 19; CONTROLLED STUDY; EX VIVO STUDY; GENE LOCUS; GENE SEQUENCE; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS TITRATION; WILD TYPE;

BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 19; DEPENDOVIRUS; DNA, VIRAL; GENETIC THERAPY; GENETIC VECTORS; GENOME, VIRAL; GREEN FLUORESCENT PROTEINS; HEP G2 CELLS; HUMANS; RECOMBINANT PROTEINS; VIRUS INTEGRATION;

ADENO-ASSOCIATED VIRUS; BACTERIA (MICROORGANISMS);

EID: 84867210498     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.08.015     Document Type: Article

References (50)

1. Blacklow N.R., Hoggan M.D., Sereno M.S., Brandt C.D., Kim H.W., Parrott R.H., Chanock R.M. A seroepidemiologic study of adenovirus-associated virus infection in infants and children. Am. J. Epidemiol. 1971, 94(4):359-366.
2. Cornu T.I., Cathomen T. Quantification of zinc finger nuclease-associated toxicity. Methods Mol. Biol. 2010, 649:237-245.
3. Daya S., Cortez N., Berns K.I. Adeno-associated virus site-specific integration is mediated by proteins of the nonhomologous end-joining pathway. J. Virol. 2009, 83(22):11655-11664.
4. Drew H.R., Lockett L.J., Both G.W. Increased complexity of wild-type adeno-associated virus-chromosomal junctions as determined by analysis of unselected cellular genomes. J. Gen. Virol. 2007, 88(6):1722-1732.
5. Dutheil N., Shi F., Dupressoir T., Linden R.M. Adeno-associated virus site-specifically integrates into a muscle-specific DNA region. Proc. Natl. Acad. Sci. USA 2000, 97(9):4862-4866.
6. Dutheil N., Yoon-Robarts M., Ward P., Henckaerts E., Skrabanek L., Berns K.I., Campagne F., Linden R.M. Characterization of the mouse adeno-associated virus AAVS1 ortholog. J. Virol. 2004, 78(16):8917-8921.
7. Fraefel C., Jacoby D.R., Lage C., Hilderbrand H., Chou J.Y., Alt F.W., Breakefield X.O., Majzoub J.A. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Mol. Med. 1997, 3(12):813-825.
8. Gabriel R., Lombardo A., Arens A., Miller J.C., Genovese P., Kaeppel C., Nowrouzi A., Bartholomae C.C., Wang J., Friedman G., Holmes M.C., Gregory P.D., Glimm H., Schmidt M., Naldini L., von Kalle C. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat. Biotechnol. 2011, 29(9):816-823.
9. Guilbaud M., Chadeuf G., Avolio F., Francois A., Moullier P., Recchia A., Salvetti A. Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration. J. Virol. 2008, 82(5):2590-2593.
10. Henckaerts E., Dutheil N., Zeltner N., Kattman S., Kohlbrenner E., Ward P., Clement N., Rebollo P., Kennedy M., Keller G.M., Linden R.M. Site-specific integration of adeno-associated virus involves partial duplication of the target locus. Proc. Natl. Acad. Sci. USA 2009, 106(18):7571-7576.
11. Henckaerts E., Linden R.M. Adeno-associated virus: a key to the human genome?. Future Virol. 2010, 5(5):555-574.
12. Hockemeyer D., Soldner F., Beard C., Gao Q., Mitalipova M., DeKelver R.C., Katibah G.E., Amora R., Boydston E.A., Zeitler B., Meng X., Miller J.C., Zhang L., Rebar E.J., Gregory P.D., Urnov F.D., Jaenisch R. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 2009, 27(9):851-857.
13. Huser D., Gogol-Doring A., Lutter T., Weger S., Winter K., Hammer E.M., Cathomen T., Reinert K., Heilbronn R. Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome. PLoS Pathog. 2010, 6(7):e1000985.
14. Kearns W.G., Afione S.A., Fulmer S.B., Pang M.C., Erikson D., Egan M., Landrum M.J., Flotte T.R., Cutting G.R. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 1996, 3(9):748-755.
15. Kotin R.M. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 1994, 5(7):793-801.
16. Kotin R.M., Siniscalco M., Samulski R.J., Zhu X.D., Hunter L., Laughlin C.A., McLaughlin S., Muzyczka N., Rocchi M., Berns K.I. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 1990, 87(6):2211-2215.
17. Lamartina S., Roscilli G., Rinaudo D., Delmastro P., Toniatti C. Lipofection of purified adeno-associated virus Rep68 protein: toward a chromosome-targeting nonviral particle. J. Virol. 1998, 72(9):7653-7658.
18. Laughlin C.A., Tratschin J.D., Coon H., Carter B.J. Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 1983, 23(1):65-73.
19. Linden R.M., Ward P., Giraud C., Winocour E., Berns K.I. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 1996, 93(21):11288-11294.
20. Linden R.M., Winocour E., Berns K.I. The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. USA 1996, 93(15):7966-7972.
21. McCarty D.M., Young S.M., Samulski R.J. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 2004, 38:819-845.
22. Meneses P., Berns K.I., Winocour E. DNA sequence motifs which direct adeno-associated virus site-specific integration in a model system. J. Virol. 2000, 74(13):6213-6216.
23. Miao C.H., Snyder R.O., Schowalter D.B., Patijn G.A., Donahue B., Winther B., Kay M.A. The kinetics of rAAV integration in the liver. Nat. Genet. 1998, 19(1):13-15.
24. Miller D.G., Rutledge E.A., Russell D.W. Chromosomal effects of adeno-associated virus vector integration. Nat. Genet. 2002, 30(2):147-148.
25. Miller D.G., Trobridge G.D., Petek L.M., Jacobs M.A., Kaul R., Russell D.W. Large-scale analysis of adeno-associated virus vector integration sites in normal human cells. J. Virol. 2005, 79(17):11434-11442.
26. Mitsui K., Suzuki K., Aizawa E., Kawase E., Suemori H., Nakatsuji N., Mitani K. Gene targeting in human pluripotent stem cells with adeno-associated virus vectors. Biochem. Biophys. Res. Commun. 2009, 388(4):711-717.
27. Muzyczka N., Berns K.I. Parvoviridae: the viruses and their replication. Field's Virol 2001, 2327-2359. Lippincott, Williams, and Wilkins, Philadelphia, PA. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
28. Nakai H., Iwaki Y., Kay M.A., Couto L.B. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J. Virol. 1999, 73(7):5438-5447.
29. Nakai H., Montini E., Fuess S., Storm T.A., Grompe M., Kay M.A. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 2003, 34(3):297-302.
30. Nakai H., Wu X., Fuess S., Storm T.A., Munroe D., Montini E., Burgess S.M., Grompe M., Kay M.A. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver. J. Virol. 2005, 79(6):3606-3614.
31. Pattanayak V., Ramirez C.L., Joung J.K., Liu D.R. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat. Methods. 2011, 8(9):765-770.
32. Philpott N.J., Giraud-Wali C., Dupuis C., Gomos J., Hamilton H., Berns K.I., Falck-Pedersen E. Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis. J. Virol. 2002, 76(11):5411-5421.
33. Philpott N.J., Gomos J., Berns K.I., Falck-Pedersen E. A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc. Natl. Acad. Sci. USA 2002, 99(19):12381-12385.
34. Ponnazhagan S., Erikson D., Kearns W.G., Zhou S.Z., Nahreini P., Wang X.S., Srivastava A. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 1997, 8(3):275-284.
35. Ramachandra C.J., Shahbazi M., Kwang T.W., Choudhury Y., Bak X.Y., Yang J., Wang S. Efficient recombinase-mediated cassette exchange at the AAVS1 locus in human embryonic stem cells using baculoviral vectors. Nucleic Acids Res. 2011, 39 (16)e, 107.
36. Recchia A., Parks R.J., Lamartina S., Toniatti C., Pieroni L., Palombo F., Ciliberto G., Graham F.L., Cortese R., La Monica N., Colloca S. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 1999, 96(6):2615-2620.
37. Recchia A., Perani L., Sartori D., Olgiati C., Mavilio F. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors. Mol. Ther. 2004, 10(4):660-670.
38. Rutledge E.A., Russell D.W. Adeno-associated virus vector integration junctions. J. Virol. 1997, 71(11):8429-8436.
39. Samulski R.J., Zhu X., Xiao X., Brook J.D., Housman D.E., Epstein N., Hunter L.A. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. Embo J. 1991, 10(12):3941-3950.
40. Schroder A.R., Shinn P., Chen H., Berry C., Ecker J.R., Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002, 110(4):521-529.
41. Smith J.R., Maguire S., Davis L.A., Alexander M., Yang F., Chandran S., Ffrench-Constant C., Pedersen R.A. Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration. Stem Cells. 2008, 26(2):496-504.
42. Surosky R.T., Urabe M., Godwin S.G., McQuiston S.A., Kurtzman G.J., Ozawa K., Natsoulis G. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol. 1997, 71(10):7951-7959.
43. Tan I., Ng C.H., Lim L., Leung T. Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton. J. Biol. Chem. 2001, 276(24):21209-21216.
44. Urcelay E., Ward P., Wiener S.M., Safer B., Kotin R.M. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J. Virol. 1995, 69(4):2038-2046.
45. Wang L., Bell P., Lin J., Calcedo R., Tarantal A.F., Wilson J.M. AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta). Mol. Ther. 2011-20, 19(11).
46. Ward P., Elias P., Linden R.M. Rescue of the adeno-associated virus genome from a plasmid vector: evidence for rescue by replication. J. Virol. 2003, 77(21):11480-11490.
47. Weitzman M.D., Kyostio S.R., Carter B.J., Owens R.A. Interaction of wild-type and mutant adeno-associated virus (AAV) Rep proteins on AAV hairpin DNA. J. Virol. 1996, 70(4):2440-2448.
48. Zhang C., Cortez N.G., Berns K.I. Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration. Hum. Gene Ther. 2007, 18(9):787-797.
49. Zolotukhin S., Potter M., Hauswirth W.W., Guy J., Muzyczka N. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 1996, 70(7):4646-4654.
50. Zou J., Sweeney C.L., Chou B.K., Choi U., Pan J., Wang H., Dowey S.N., Cheng L., Malech H.L. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood 2011, 117(21):5561-5572.